From pharmacogenetics to imaging pharmacogenetics: elucidating mechanisms of antidepressant response.

about

From pharmacogenetics to imaging pharmacogenetics: elucidating mechanisms of antidepressant response.

Item

http://www.wikidata.org/entity/Q52837901

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

From pharmacogenetics to imagi ...... ms of antidepressant response.

@en

From pharmacogenetics to imagi ...... ms of antidepressant response.

@nl

type

Item

label

From pharmacogenetics to imagi ...... ms of antidepressant response.

@en

From pharmacogenetics to imagi ...... ms of antidepressant response.

@nl

prefLabel

From pharmacogenetics to imagi ...... ms of antidepressant response.

@en

From pharmacogenetics to imagi ...... ms of antidepressant response.

@nl

P1476

From pharmacogenetics to imagi ...... sms of antidepressant response

@en

P2860

Neuroimaging in psychiatric pharmacogenetics research: the promise and pitfalls

Use of magnetic resonance imaging in pharmacogenomics

Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.

A systematic review of relations between resting-state functional-MRI and treatment response in major depressive disorder

Frontal and limbic activation during inhibitory control predicts treatment response in major depressive disorder

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.

Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors

Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.

Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.

P304

927-930

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.2217/PGS-2017-0082

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Henrik Walter

Eva J Brandl

P577

2017-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28639501

http://www.w3.org/2001/XMLSchema#string